Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Intensive Care Med. 2018 Oct 21;44(11):1849–1858. doi: 10.1007/s00134-018-5328-0

Table 1: MESSI population with genotype and plasma ANG2 measured.

Continuous data are compared by the Wilcoxon ranksum test and categorical data by a chi square test. SOFA: sequential organ failure assessment score; ABG: arterial blood gas; PBW: predicted body weight. PEEP: positive end-expiratory pressure.

ARDS (n=289) Non-ARDS (n=414) p-value
Age 60 (51 – 69) 62 (52 – 71) 0.095
Female 119 (41.2%) 181 (43.7%) 0.502
European ancestry 178 (61.6%) 226 (54.6%) 0.022
African ancestry 91 (31.5%) 163 (39.4%)
Asian ancestry 13 (4.8%) 16 (3.9%)
Genetically admixed 7 (2.4%) 9 (2.2%)
APACHE III 84 (69 – 105) 71 (57 – 88) <0.001
Infectious source (primary) <0.001
 Pulmonary 172 (60%) 137 (33%)
 Genitourinary 16 (6%) 71 (17%)
 Abdominal 38 (13%) 63 (15%)
 Blood 12 (4%) 44 (11%)
 Unknown 35 (12%) 67 (16%)
Comorbidities
 Immunocompromised 142 (49%) 190 (46%) 0.397
 Malignancy 108 (37%) 141 (34%) 0.366
 Cirrhosis, decompensated 23 (8%) 13 (3%) 0.004
 Diabetes 76 (26%) 139 (34%) 0.043
SOFA score day 0 5 (3 – 7) 3 (1 – 5) <0.001
PaO2/FiO2 ratio day 0 122 (76 – 190) 215 (117 – 323) <0.001
Number, % with ABG on day 0 n=222, 77% n=119, 29%
Intubated on day 0 192 (66%) 69 (17%) <0.001
 Tidal volume per kg PBW 7.1 (6.4 – 8.1) 7.3 (6.8 – 8.6) 0.213
 PEEP (cm H2O) 5(5–8) 5(5–5) 0.012
 Plateau pressure (cm H2O) 23 (18 – 30) 20(17 – 24) 0.049
Vasoactive support day 0 181 (63%) 159 (39%) <0.001
Measured ANG2 ng/ml 10.0 (5.2 – 21.6) 7.9 (3.9 – 16.0) <0.001
Mortality, 30 day 197 (68.2%) 157 (38.0%) <0.001